Data gathered: February 1
Alternative Data for Scholar Rock
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 30 | Sign up | Sign up | Sign up |
| Sentiment | 84 | Sign up | Sign up | Sign up |
| Webpage traffic | 13,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 9 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,942 | Sign up | Sign up | Sign up |
| Twitter Followers | 582 | Sign up | Sign up | Sign up |
| Twitter Mentions | 36 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 199 | Sign up | Sign up | Sign up |
About Scholar Rock
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
| Price | $40.38 |
| Target Price | Sign up |
| Volume | 1,580,000 |
| Market Cap | $3.78B |
| Year Range | $7.07 - $46.73 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Scholar Rock’s (SRRK) “Outperform” Rating Reiterated at WedbushFebruary 1 - ETF Daily News |
 |
Exchange Traded Concepts LLC Sells 82,792 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK)January 30 - ETF Daily News |
 |
Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment DataJanuary 29 - SeekingAlpha |
Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)January 28 - Finnhub |
|
Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership TransitionJanuary 28 - Finnhub |
|
|
Scholar Rock Holding Co. (NASDAQ:SRRK) Receives Consensus Rating of “Buy” from AnalystsJanuary 21 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 16M | -16M | -64M | -64M | -0.664 |
| Q2 '24 | 0 | 17M | -17M | -59M | -59M | -0.600 |
| Q1 '24 | 0 | 16M | -16M | -57M | -58M | -0.590 |
| Q4 '23 | 12M | 14M | -20M | -46M | -47M | -0.500 |
| Q3 '23 | 500,000 | 13M | -13M | -42M | -43M | -0.530 |
Insider Transactions View All
| Ho Junlin filed to sell 195,037 shares at $44.2. January 21 '25 |
| Parlavecchio Caryn filed to sell 145,554 shares at $44.2. January 21 '25 |
| Qatanani Mo filed to sell 135,421 shares at $44.2. January 21 '25 |
| Sacco Tracey filed to sell 45,395 shares at $44.2. January 21 '25 |
| Marantz Jing L. filed to sell 67,200 shares at $44.2. January 21 '25 |
Similar companies
Read more about Scholar Rock (SRRK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Scholar Rock?
The Market Cap of Scholar Rock is $3.78B.
What is the current stock price of Scholar Rock?
Currently, the price of one share of Scholar Rock stock is $40.38.
How can I analyze the SRRK stock price chart for investment decisions?
The SRRK stock price chart above provides a comprehensive visual representation of Scholar Rock's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Scholar Rock shares. Our platform offers an up-to-date SRRK stock price chart, along with technical data analysis and alternative data insights.
Does SRRK offer dividends to its shareholders?
As of our latest update, Scholar Rock (SRRK) does not offer dividends to its shareholders. Investors interested in Scholar Rock should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Scholar Rock?
Some of the similar stocks of Scholar Rock are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.